Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07FDL
|
|||
Former ID |
DNC012519
|
|||
Drug Name |
N-(2,3-Dihydro-1H-phenalen-2-yl)-acetamide
|
|||
Synonyms |
N-(2,3-dihydro-1H-phenalen-2-yl)acetamide; SCHEMBL8406961; CHEMBL320810; ZINC21623; NSODBKSYAOTJPJ-UHFFFAOYSA-N; N-[(2,3-Dihydro-1H-phenalen)-2-yl]acetamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H15NO
|
|||
Canonical SMILES |
CC(=O)NC1CC2=CC=CC3=C2C(=CC=C3)C1
|
|||
InChI |
1S/C15H15NO/c1-10(17)16-14-8-12-6-2-4-11-5-3-7-13(9-14)15(11)12/h2-7,14H,8-9H2,1H3,(H,16,17)
|
|||
InChIKey |
NSODBKSYAOTJPJ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Melatonin receptor type 1A (MTNR1A) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Circadian entrainment | ||||
Reactome | Class A/1 (Rhodopsin-like receptors) | |||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Small Ligand GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors. J Med Chem. 1996 Aug 2;39(16):3089-95. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.